Back to List View Graph View

B-cell

B cells are lymphocytes derived from hematopoietic stem cells in bone marrow that play central roles in adaptive immunity through both antibody production and antigen presentation.

Where the papers sit

14 papers from the last 6 months study b-cell directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 1 observational · 4 human data · 5 preclinical · 4 unclassified

Themes 3 themes

  • Immune Cell Interactions

    Single-cell, spatial and multi-omics profiling is mapping how B cells interact with T cells, NK cells and tissue-specific immune networks. Genetic variants, including rs57494551, are linked to IgM+ CXCR5+ B-cell infiltration and disease risk. Immune-metabolic pathways and tertiary lymphoid structures are emerging as therapeutic targets, while AB-101 aims to enhance antibody-mediated cytotoxicity. The common direction is mechanistic immune mapping, but therapeutic benefit remains disease-specific.

    6 papers · 42.9%

  • Myasthenia Gravis Therapies

    Myasthenia gravis treatment is moving toward more targeted approaches alongside comparative evaluation of established therapies. Antigen-specific chimeric autoantibody receptor T cells are being developed to eliminate acetylcholine receptor-specific B cells. Clinical trials and Bayesian network analysis emphasize efficacy, safety, combination therapy and immune reconstitution. Whether these strategies produce durable benefit with acceptable immune effects remains open.

    3 papers · 21.4%

  • Others — Antigen Targeting and Safety

    Vaccine development is moving toward multi-epitope, mosaic and intranasal designs that seek broader, more durable protection. Epitope screening and antigen avidity recur as ways to shape B-cell maturation and clonal hierarchy. SARS-CoV-2, SARS-CoV, human metapneumovirus and varicella-zoster virus provide the main testing ground. Teclistamab pharmacovigilance adds a separate focus on adverse-event detection rather than a shared vaccine direction.

    5 papers · 35.7%

Papers

The 14 papers from the last 6 months that study b-cell directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Immune Cell Interactions (6)
  1. Single-Cell Profiling Reveals Clonally Expanded CX3CR1+ T Cells in Anti-NMDA Receptor Encephalitis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 9 Sept 2026 PMID 42711907
  2. rs57494551 increases CXCR5 expression and IgM+ CXCR5+ B-cell infiltration in the portal area of primary biliary cholangitis. Journal of gastroenterology · 10 Aug 2026 PMID 42573624
  3. Targeting the immune-metabolic axis reverses orthodontics-induced systemic pathology. Signal transduction and targeted therapy · 2 Aug 2026 PMID 42543382
  4. High affinity CD16v/v allogeneic NK cell therapy, AB-101, enhances antibody-mediated cytotoxicity in B-cell driven diseases. Cytotherapy · 20 Jul 2026 PMID 42475795
  5. Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy. Cancer discovery · 24 Jun 2026 PMID 42339989
  6. Immune cell-specific genetic architecture of Alzheimer's disease revealed by multi-omics analysis for therapeutic target discovery and prioritization. Translational psychiatry · 22 Jun 2026 PMID 42331779
Myasthenia Gravis Therapies (3)
  1. Generalized myasthenia gravis: Clinical trials to watch. Med (New York, N.Y.) · 11 Sept 2026 PMID 42727567
  2. Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models. Nature communications · 20 Aug 2026 PMID 42624846
  3. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology · 17 Jul 2026 PMID 42467874
Others — Antigen Targeting and Safety (5)
  1. Computational prediction of a multi-epitope Human Metapneumovirus vaccine candidate through integrated reverse vaccinology and pan-genomic approaches. PloS one · 15 Sept 2026 PMID 42743349
  2. Screening and identification of B-cell epitopes on the gH protein of varicella-zoster virus. Archives of microbiology · 15 Sept 2026 PMID 42742725
  3. Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system. Hematology (Amsterdam, Netherlands) · 15 Sept 2026 PMID 42742109
  4. Immunization with mosaic nanoparticles reveals that antigen avidity shapes the clonal hierarchy of the B cell response. Science translational medicine · 12 Aug 2026 PMID 42585293
  5. Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid. PLoS pathogens · 24 Jul 2026 PMID 42497177

By study type

Observational studies and case reports (1)
  1. Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system. Hematology (Amsterdam, Netherlands) · 15 Sept 2026 PMID 42742109
Human data, design not indexed (4)
  1. Computational prediction of a multi-epitope Human Metapneumovirus vaccine candidate through integrated reverse vaccinology and pan-genomic approaches. PloS one · 15 Sept 2026 PMID 42743349
  2. Screening and identification of B-cell epitopes on the gH protein of varicella-zoster virus. Archives of microbiology · 15 Sept 2026 PMID 42742725
  3. Generalized myasthenia gravis: Clinical trials to watch. Med (New York, N.Y.) · 11 Sept 2026 PMID 42727567
  4. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology · 17 Jul 2026 PMID 42467874
Preclinical: animal, cell and lab studies (5)
  1. Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models. Nature communications · 20 Aug 2026 PMID 42624846
  2. Immunization with mosaic nanoparticles reveals that antigen avidity shapes the clonal hierarchy of the B cell response. Science translational medicine · 12 Aug 2026 PMID 42585293
  3. Targeting the immune-metabolic axis reverses orthodontics-induced systemic pathology. Signal transduction and targeted therapy · 2 Aug 2026 PMID 42543382
  4. Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid. PLoS pathogens · 24 Jul 2026 PMID 42497177
  5. High affinity CD16v/v allogeneic NK cell therapy, AB-101, enhances antibody-mediated cytotoxicity in B-cell driven diseases. Cytotherapy · 20 Jul 2026 PMID 42475795
Unclassified: not yet indexed with MeSH (4)
  1. Single-Cell Profiling Reveals Clonally Expanded CX3CR1+ T Cells in Anti-NMDA Receptor Encephalitis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 9 Sept 2026 PMID 42711907
  2. rs57494551 increases CXCR5 expression and IgM+ CXCR5+ B-cell infiltration in the portal area of primary biliary cholangitis. Journal of gastroenterology · 10 Aug 2026 PMID 42573624
  3. Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy. Cancer discovery · 24 Jun 2026 PMID 42339989
  4. Immune cell-specific genetic architecture of Alzheimer's disease revealed by multi-omics analysis for therapeutic target discovery and prioritization. Translational psychiatry · 22 Jun 2026 PMID 42331779